4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000899243-22-006421
Chief Legal Officer acquired 22,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Keane Raymond T · Chief Legal Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 1 in the form | +22,500 | 24,124 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-02-11 | Grant or award : show line 2 in the form Stock Option (Right to Buy) | +45,000 | 45,000 | D |
Loading xslF345X03/doc4.xml…